Susan L. Lang founded XIL Health, a leading, woman-owned health analytics and technology company. As CEO, Lang works with startups as well as Fortune 100 PBMs, health plans, drug manufacturers and retail pharmacy companies. In 2020, XIL Health launched XIL Impact, a SaaS technology platform that provides real time analytics and economics to pharmacy clients. Previously, Lang served as a C-Suite executive at Express Scripts where her division drove earnings growth that saved billions in drug costs. Lang has a robust knowledge of pharmaceutical economics and healthcare technology and is passionate about helping companies compete by leveraging disruptive technologies that redistribute drug economics to benefit consumers.